What the Research Says About Saffron

Multiple peer-reviewed clinical trials have explored saffron's relationship with mood. Several systematic reviews and meta-analyses have found that saffron extract performed comparably to standard treatments in controlled studies of mild-to-moderate mood symptoms, though research is ongoing and results vary across populations.

Notable studies include Hausenblas et al. (2013), a systematic review examining six clinical trials, and Lopresti and Drummond (2014), which reached similar conclusions across multiple controlled trials using standardized saffron extracts.

Researchers continue to study saffron's mechanism of action, particularly its compounds crocin and safranal, and their relationship to mood-regulation pathways.

Researchers have examined saffron's compounds — including crocin and crocetin — in trials focused on age-related cognitive function. The most-cited work in this area comes from Akhondzadeh and colleagues at Tehran University of Medical Sciences, who conducted multi-month controlled trials comparing saffron extract to standard interventions.

A 2010 study compared saffron to a commonly prescribed cognitive medication over a 22-week period, with both showing comparable cognitive measures. A 2014 follow-up examined saffron's effects in adults with mild cognitive impairment over 12 months.

Research on the underlying mechanism focuses on crocin's apparent ability to cross the blood-brain barrier and its observed antioxidant activity in neural tissue.

Saffron is one of the most chemically interesting spices, containing over 150 volatile compounds. Three have drawn particular research attention: crocin, crocetin, and safranal.

Crocin is responsible for saffron's deep red-orange color. It's a carotenoid — the same compound family that gives carrots and tomatoes their color. Laboratory research has measured crocin's antioxidant activity at multiple times that of vitamin E in controlled conditions.

Crocetin shares many of crocin's properties and has been studied for its bioavailability and effects on inflammation pathways.

Safranal is responsible for saffron's distinctive aroma. Research has explored its antioxidant and calming properties in laboratory and animal studies.

Most antioxidant research on saffron has been conducted in laboratory settings with specific compounds at controlled concentrations. While these findings establish that saffron's bioactive compounds have meaningful biological activity, the relationship to dietary saffron consumption is still being mapped.

Several research groups have examined saffron's role in studies of premenstrual symptoms, building on traditional uses across multiple cultures.

Agha-Hosseini and colleagues conducted a 2008 randomized controlled trial published in BJOG examining saffron extract's effects on premenstrual symptoms over two menstrual cycles, finding measurable differences compared to placebo on multiple symptom scales.

Ayati and colleagues published a 2020 systematic review aggregating findings across multiple trials in this area, with generally consistent positive results across studies.

Research has examined both physical symptoms and emotional symptoms commonly associated with the premenstrual phase.

Saffron (Crocus sativus L.) has been studied as a botanical ingredient for everyday sleep quality, restfulness, and stress-related mood. Notable peer-reviewed work includes Lopresti et al. (2020), a 28-day randomized, double-blind, placebo-controlled trial of a standardized saffron extract in 63 adults with self-reported poor sleep, and a follow-up dose-ranging trial by Lopresti et al. (2021) in 120 adults with unsatisfactory sleep that also examined evening melatonin and cortisol.

A 6-week trial by Pachikian et al. (2021) used both questionnaires and wrist actigraphy in adults with mild-to-moderate sleep complaints, while Kell et al. (2017) and Jackson et al. (2021) explored mood, perceived stress, and acute stress response in healthy adults. Two systematic reviews — Lian et al. (2022) in Sleep Medicine and Sadat Rafiei et al. (2023) — synthesize this work.

Findings point to a supportive role for standardized saffron extract on self-reported sleep and stress-related mood measures, though the authors consistently note that trials are short (mostly 4–8 weeks), populations are self-selected for subclinical complaints, and larger long-term studies are needed.

The pigments responsible for saffron's color and aroma — crocin and crocetin (carotenoids) and safranal — have been studied for antioxidant and anti-inflammatory activity in laboratory and animal models.

In vitro work by Assimopoulou et al. (2005) demonstrated radical-scavenging activity of saffron extract and its constituents, and Hosseinzadeh et al. (2009) showed antioxidant activity of saffron stigma extracts and of crocin and safranal across multiple assays. Reviews by Boskabady and Farkhondeh (2016), Zeinali et al. (2019), and Cerdá-Bernad et al. (2022) summarize preclinical evidence that crocin, crocetin, and safranal modulate oxidative-stress and inflammatory markers (including MDA, glutathione, SOD, NF-κB, TNF-α, and IL-6) in cell and animal systems.

Human clinical evidence is more limited and still developing: meta-analyses by Asbaghi et al. (2021), Morvaridzadeh et al. (2021), Abedi et al. (2023), and Bahari et al. (2025) have pooled small numbers of trials and reported modest, condition- and dose-dependent effects on biomarkers such as MDA, total antioxidant capacity, and (in some subgroups) CRP and TNF-α, with notable heterogeneity.

Findings point to a supportive antioxidant/anti-inflammatory role for saffron and its constituents, while the authors uniformly call for larger, more rigorous human trials.